title: Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis.
abstract: BACKGROUND
  Fibrin-related markers such as soluble fibrin (SF) and D-dimer are considered useful for the diagnosis of thrombosis. However, the evidence for diagnosis of thrombosis by fibrin-related markers is not well-established.
  
  
  OBJECTIVE
  To evaluate the cutoff values of D-dimer and SF in the diagnosis of thrombosis.
  
  
  METHODS
  Plasma concentrations of SF and D-dimer were measured in 784 inpatients suspected of having thrombosis between 1 August 2003 and 31 December 2004, and then correlated with thrombosis.
  
  
  CONCLUSIONS
  Plasma concentrations of D-dimer and SF were significantly higher in patients with disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT) and cerebral thrombosis, compared with those in patients without thrombosis. When cutoff values of > 3.0 microg mL(-1) for D-dimer and > 6.0 microg mL(-1) for SF were used for the diagnosis, more than 50% of patients (with the exception of liver transplant patients and postoperative patients) had thrombosis. Receiver operating characteristic analysis showed that SF was more useful than D-dimer for the diagnosis of thrombosis (i.e. DVT and DIC). The cutoff value of D-dimer (7.87 microg mL(-1)) was the same for DVT and DIC, while that of SF was slightly lower for DVT (7.05 microg mL(-1)) than for DIC (8.60 microg mL(-1)). Our findings suggest that high levels of plasma fibrin-related markers reflect high risk for thrombosis.
authors.affiliation: Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Edobashi, Tsu, Japan. adahide@clin.medic.mie-u.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Wada
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Abe
authors.forename: T
authors.initials: T
authors.lastname: Hatada
authors.forename: N
authors.initials: N
authors.lastname: Yamada
authors.forename: A
authors.initials: A
authors.lastname: Sudo
authors.forename: A
authors.initials: A
authors.lastname: Uchida
authors.forename: T
authors.initials: T
authors.lastname: Nobori
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D001847:Bone Diseases / Q000097:blood / Q000150:complications; D003141:Communicable Diseases / Q000097:blood / Q000150:complications; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D005260:Female; D005337:Fibrin / Q000378:metabolism*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D006801:Humans; D020767:Intracranial Thrombosis / Q000097:blood / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000150:complications; D012372:ROC Curve; D012307:Risk Factors; D020246:Venous Thrombosis / Q000097:blood* / Q000209:etiology
chemical_list: D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D; D005337:Fibrin